Stéphanie Gout

893 total citations
11 papers, 722 citations indexed

About

Stéphanie Gout is a scholar working on Molecular Biology, Oncology and Immunology and Allergy. According to data from OpenAlex, Stéphanie Gout has authored 11 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Immunology and Allergy. Recurrent topics in Stéphanie Gout's work include RNA modifications and cancer (3 papers), Cell Adhesion Molecules Research (3 papers) and RNA Research and Splicing (3 papers). Stéphanie Gout is often cited by papers focused on RNA modifications and cancer (3 papers), Cell Adhesion Molecules Research (3 papers) and RNA Research and Splicing (3 papers). Stéphanie Gout collaborates with scholars based in France, Canada and United States. Stéphanie Gout's co-authors include Jacques Huot, P. Tremblay, Béatrice Eymin, Sylvie Gazzéri, Élisabeth Brambilla, François Houle, Chantale Morin, Sylvie Lantuéjoul, Valérie Edmond and Jean‐Luc Coll and has published in prestigious journals such as PLoS ONE, Cancer Research and Oncogene.

In The Last Decade

Stéphanie Gout

11 papers receiving 718 citations

Peers

Countries citing papers authored by Stéphanie Gout

Since Specialization

Citations

This map shows the geographic impact of Stéphanie Gout's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphanie Gout with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphanie Gout more than expected).

Fields of papers citing papers by Stéphanie Gout

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphanie Gout. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphanie Gout. The network helps show where Stéphanie Gout may publish in the future.

Co-authorship network of co-authors of Stéphanie Gout

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphanie Gout. A scholar is included among the top collaborators of Stéphanie Gout based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphanie Gout. Stéphanie Gout is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	VEGF165b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angiogenic therapies through a β1 integrin/VEGFR autocrine loop 2018 ·Oncogene ·(unknown), Chérine Abou Fayçal, Tao Jia, Stéphanie Gout, Michelle Kéramidas, (unknown), Nicolas Lemaître, (unknown), Jean‐Luc Coll, Anne‐Claire Toffart, Denis Moro‐Sibilot, Corinne Albigès‐Rizo, Véronique Josserand, Eva Faurobert, Christian Brambilla, Élisabeth Brambilla, Sylvie Gazzéri, Béatrice Eymin	45
2	A new function of the splicing factor SRSF2 in the control of E2F1-mediated cell cycle progression in neuroendocrine lung tumors 2013 ·Cell Cycle ·Valérie Edmond, (unknown), Stéphanie Gout, Élisabeth Brambilla, Sylvie Gazzéri, Béatrice Eymin	27
3	Abnormal Expression of the Pre-mRNA Splicing Regulators SRSF1, SRSF2, SRPK1 and SRPK2 in Non Small Cell Lung Carcinoma 2012 ·PLoS ONE ·Stéphanie Gout, Élisabeth Brambilla, (unknown), (unknown), Sylvie Lantuéjoul, Sylvie Gazzéri, Béatrice Eymin	124
4	Survival advantages conferred to colon cancer cells by E-selectin-induced activation of the PI3K-NFκB survival axis downstream of Death receptor-3 2011 ·BMC Cancer ·(unknown), (unknown), François Houle, (unknown), Stéphanie Gout, P. Tremblay, Éric R. Paquet, Roscoe Klinck, François A. Auger, Jacques Huot	34
5	The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo 2010 ·Oncogene ·(unknown), Stéphanie Gout, M. Kéramidas, Valérie Edmond, Jean‐Luc Coll, Christian Brambilla, Élisabeth Brambilla, Sylvie Gazzéri, Béatrice Eymin	69
6	Role of Cancer Microenvironment in Metastasis: Focus on Colon Cancer 2008 ·Cancer Microenvironment ·Stéphanie Gout, Jacques Huot	144
7	Selectins and selectin ligands in extravasation of cancer cells and organ selectivity of metastasis 2007 ·Clinical & Experimental Metastasis ·Stéphanie Gout, P. Tremblay, Jacques Huot	102
8	Death Receptor-3, a New E-Selectin Counter-Receptor that Confers Migration and Survival Advantages to Colon Carcinoma Cells by Triggering p38 and ERK MAPK Activation 2006 ·Cancer Research ·Stéphanie Gout, Chantale Morin, François Houle, Jacques Huot	83
9	Laminin-5-integrin interaction signals through PI 3-kinase and Rac1b to promote assembly of adherens junctions in HT-29 cells 2005 ·Journal of Cell Science ·Nicolas T. Chartier, (unknown), Stéphanie Gout, Géraldine Pawlak, Christiane Marie, Paulo Matos, Marc R. Block, Muriel R. Jacquier‐Sarlin	33
10	Early enterocytic differentiation of HT-29 cells: biochemical changes and strength increases of adherens junctions 2004 ·Experimental Cell Research ·Stéphanie Gout, Christiane Marie, (unknown), (unknown), Marc R. Block, Muriel R. Jacquier‐Sarlin	28
11	Developmentally regulated activity of CRM1/XPO1 during early Xenopus embryogenesis 2000 ·Journal of Cell Science ·Mary Callanan, N. Kudo, Stéphanie Gout, (unknown), Minoru Yoshida, Stéfan Dimitrov, Saadi Khochbin	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact